Xeris Biopharma Holdings, Inc.

HSBC HOLDINGS PLC XERS

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/30/2026

Shares

31,175

Value ($000)

183

Weight

0.0%

2021 Q4 - 2026 Q1 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/30/2026	183	0.0%	31,175	3/31/2026
2025 Q1	5/14/2025	88	0.0%	16,205	3/31/2025
2024 Q4	2/14/2025	56	0.0%	16,312	12/31/2024
2024 Q3	11/14/2024	67	0.0%	23,661	9/30/2024
2024 Q2	8/12/2024	53	0.0%	23,976	6/30/2024
2024 Q1	5/15/2024	55	0.0%	25,060	3/31/2024
2023 Q4	2/12/2024	25	0.0%	10,616	12/31/2023
2023 Q3	11/13/2023	20	0.0%	10,616	9/30/2023
2023 Q2	8/11/2023	28	0.0%	10,616	6/30/2023
2023 Q1	5/15/2023	17	0.0%	10,616	3/31/2023
2022 Q4	2/14/2023	13	0.0%	10,616	12/31/2022
2022 Q3	11/14/2022	17	0.0%	10,616	9/30/2022
2022 Q2	8/11/2022	16	0.0%	10,616	6/30/2022
2022 Q1	5/16/2022	34	0.0%	13,090	3/31/2022
2021 Q4	2/11/2022	42	0.0%	14,392	12/31/2021